N6-methyladenosine in DNA promotes genome stability
Brooke Conti,Leo Novikov,Deyan Tong,Qing Xiang,Chuong Nguyen,Savon Vigil,Thomas J McLellan,Nancy De La Cruz,Reshma T Veettil,Prashant Pradhan,Parag Sahasrabudhe,Jason D Arroyo,Lei Shang,Benjamin R Sabari,David J Shields,Mariano Oppikofer
DOI: https://doi.org/10.1101/2024.07.20.604187
2024-07-20
Abstract:DNA base lesions, such as incorporation of uracil into DNA or base mismatches, can be mutagenic and toxic to replicating cells. To discover factors in repair of genomic uracil, we performed a CRISPR knockout screen in the presence of floxuridine, a chemotherapeutic agent that incorporates uracil and fluoro-uracil into DNA. We identified known factors, such as uracil DNA N-glycosylase (UNG), but also unknown factors, such as the N6-adenosine methyltransferase, METTL3, as required to overcome floxuridine-driven cytotoxicity. Visualized with immunofluorescence, the product of METTL3 activity, N6-methyladenosine, formed nuclear foci in cells treated with floxuridine. The observed N6-methyladenosine was embedded in DNA, called 6mA, which was confirmed using mass spectrometry. METTL3 and 6mA were required for repair of lesions driven by additional base damaging agents, including raltitrexed, gemcitabine, and hydroxyurea. Our results establish a role for METTL3 and 6mA to promote genome stability in mammalian cells, specially in response to base damage.
Molecular Biology